Role of ERRF, a novel ER-related nuclear factor, in the growth control of er-positive human breast cancer cells

American Journal of Pathology

Volumn 180, Issue 3, 2012, Pages 1189-1201

  Su, Dan ^a   Fu, Xiaoying ^b   Fan, Songqing ^c   Wu, Xiao ^a   Wang, Xin Xin ^d   Fu, Liya ^a   Dong, Xue Yuan ^b   Ni, Jianping Jenny ^b   Fu, Li ^d   Zhu, Zhengmao ^a   Dong, Jin Tang ^a,b  

^a NANKAI UNIVERSITY   (China)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CENTRAL SOUTH UNIVERSITY   (China)

^d TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR RECEPTOR FACTOR; MESSENGER RNA; PROGESTERONE RECEPTOR; UNCLASSIFIED DRUG;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; CANCER CELL; CANCER GROWTH; CANCER STAGING; CANCER SURVIVAL; CARCINOGENESIS; CONTROLLED STUDY; FEMALE; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; UPREGULATION;

ADULT; AGED; ANIMALS; BREAST NEOPLASMS; CELL LINE, TUMOR; ESTROGEN RECEPTOR ALPHA; FEMALE; GENE KNOCKDOWN TECHNIQUES; GENES, ERBB-2; HUMANS; MICE; MICE, INBRED BALB C; MICE, NUDE; MIDDLE AGED; NEOPLASM TRANSPLANTATION; NUCLEAR PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; RNA, SMALL INTERFERING; TRANSPLANTATION, HETEROLOGOUS; UP-REGULATION;

EID: 84863158613     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2011.11.025     Document Type: Article

References (36)

1. R. Siegel, E. Ward, O. Brawley, A. Jemal Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths CA Cancer J Clin 61 2011 212 236
2. J. Russo, I.H. Russo The role of estrogen in the initiation of breast cancer J Steroid Biochem Mol Biol 102 2006 89 96
3. J.D. Yager, N.E. Davidson Estrogen carcinogenesis in breast cancer N Engl J Med 354 2006 270 282
4. M. Matsuda, T. Imaoka, A.J. Vomachka, G.A. Gudelsky, Z. Hou, M. Mistry, J.P. Bailey, K.M. Nieport, D.J. Walther, M. Bader, N.D. Horseman Serotonin regulates mammary gland development via an autocrine-paracrine loop Dev Cell 6 2004 193 203
5. E. Anderson, R.B. Clarke, A. Howell Estrogen responsiveness and control of normal human breast proliferation J Mammary Gland Biol Neoplasia 3 1998 23 35
6. E. Anderson, R.B. Clarke Steroid receptors and cell cycle in normal mammary epithelium J Mammary Gland Biol Neoplasia 9 2004 3 13
7. K. Polyak Breast cancer: origins and evolution J Clin Invest 117 2007 3155 3163
8. J. Russo, X. Ao, C. Grill, I.H. Russo Pattern of distribution of cells positive for estrogen receptor α and progesterone receptor in relation to proliferating cells in the mammary gland Breast Cancer Res Treat 53 1999 217 227
9. D.A. Zajchowski, R. Sager, L. Webster Estrogen inhibits the growth of estrogen receptor-negative, but not estrogen receptor-positive, human mammary epithelial cells expressing a recombinant estrogen receptor Cancer Res 53 1993 5004 5011
10. B.K. Lundholt, M.W. Madsen, A.E. Lykkesfeldt, O.W. Petersen, P. Briand Characterization of a nontumorigenic human breast epithelial cell line stably transfected with the human estrogen receptor (ER) cDNA Mol Cell Endocrinol 119 1996 47 59
11. M.J. Pilat, J.K. Christman, S.C. Brooks Characterization of the estrogen receptor transfected MCF10A breast cell line 139B6 Breast Cancer Res Treat 37 1996 253 266
12. S. Ali, R.C. Coombes Endocrine-responsive breast cancer and strategies for combating resistance Nat Rev Cancer 2 2002 101 112
13. R. Clarke, M.C. Liu, K.B. Bouker, Z. Gu, R.Y. Lee, Y. Zhu, T.C. Skaar, B. Gomez, K. O'Brien, Y. Wang, L.A. Hilakivi-Clarke Antiestrogen resistance in breast cancer and the role of estrogen receptor signaling Oncogene 22 2003 7316 7339
14. N. Bardeesy, K.H. Cheng, J.H. Berger, G.C. Chu, J. Pahler, P. Olson, A.F. Hezel, J. Horner, G.Y. Lauwers, D. Hanahan, R.A. DePinho Smad4 is dispensable for normal pancreas development yet critical in progression and tumor biology of pancreas cancer Genes Dev 20 2006 3130 3146
15. R.L. Strausberg, E.A. Feingold, L.H. Grouse Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences Proc Natl Acad Sci U S A 99 2002 16899 16903
16. T. Sjoblom, S. Jones, L.D. Wood, D.W. Parsons, J. Lin, T.D. Barber, D. Mandelker, R.J. Leary, J. Ptak, N. Silliman, S. Szabo, P. Buckhaults, C. Farrell, P. Meeh, S.D. Markowitz, J. Willis, D. Dawson, J.K. Willson, A.F. Gazdar, J. Hartigan, L. Wu, C. Liu, G. Parmigiani, B.H. Park, K.E. Bachman, N. Papadopoulos, B. Vogelstein, K.W. Kinzler, V.E. Velculescu The consensus coding sequences of human breast and colorectal cancers Science 314 2006 268 274
17. J.C. Ahomadegbe, S. Tourpin, M. Kaghad, L. Zelek, M. Vayssade, M.C. Mathieu, F. Rochard, M. Spielmann, T. Tursz, D. Caput, G. Riou, J. Benard Loss of heterozygosity, allele silencing and decreased expression of p73 gene in breast cancers: prevalence of alterations in inflammatory breast cancers Oncogene 19 2000 5413 5418
18. D. Smedley, S. Sidhar, S. Birdsall, D. Bennett, M. Herlyn, C. Cooper, J. Shipley Characterization of chromosome 1 abnormalities in malignant melanomas Genes Chromosomes Cancer 28 2000 121 125
19. X.Y. Dong, P. Guo, J. Boyd, X. Sun, Q. Li, W. Zhou, J.T. Dong Implication of snoRNA U50 in human breast cancer J Genet Genomics 36 2009 447 454
20. X.Y. Dong, C. Rodriguez, P. Guo, X. Sun, J.T. Talbot, W. Zhou, J. Petros, Q. Li, R.L. Vessella, A.S. Kibel, V.L. Stevens, E.E. Calle, J.T. Dong SnoRNA U50 is a candidate tumor-suppressor gene at 6q14.3 with a mutation associated with clinically significant prostate cancer Hum Mol Genet 17 2008 1031 1042
21. M.D. Ruopp, N.J. Perkins, B.W. Whitcomb, E.F. Schisterman Youden Index and optimal cut-point estimated from observations affected by a lower limit of detection Biom J 50 2008 419 430
22. A.E. Lash, C.M. Tolstoshev, L. Wagner, G.D. Schuler, R.L. Strausberg, G.J. Riggins, S.F. Altschul SAGEmap: a public gene expression resource Genome Res 10 2000 1051 1060
23. R.M. Neve, K. Chin, J. Fridlyand, J. Yeh, F.L. Baehner, T. Fevr, L. Clark, N. Bayani, J.P. Coppe, F. Tong, T. Speed, P.T. Spellman, S. DeVries, A. Lapuk, N.J. Wang, W.L. Kuo, J.L. Stilwell, D. Pinkel, D.G. Albertson, F.M. Waldman, F. McCormick, R.B. Dickson, M.D. Johnson, M. Lippman, S. Ethier, A. Gazdar, J.W. Gray A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes Cancer Cell 10 2006 515 527
24. A.F. Gazdar, V. Kurvari, A. Virmani, L. Gollahon, M. Sakaguchi, M. Westerfield, D. Kodagoda, V. Stasny, H.T. Cunningham, I.I. Wistuba, G. Tomlinson, V. Tonk, R. Ashfaq, A.M. Leitch, J.D. Minna, J.W. Shay Characterization of paired tumor and non-tumor cell lines established from patients with breast cancer Int J Cancer 78 1998 766 774
25. D.R. Rhodes, J. Yu, K. Shanker, N. Deshpande, R. Varambally, D. Ghosh, T. Barrette, A. Pandey, A.M. Chinnaiyan ONCOMINE: a cancer microarray database and integrated data-mining platform Neoplasia 6 2004 1 6
26. G. Arpino, L. Wiechmann, C.K. Osborne, R. Schiff Crosstalk between the estrogen receptor and the HER tyrosine kinase receptor family: molecular mechanism and clinical implications for endocrine therapy resistance Endocr Rev 29 2008 217 233
27. L.C. Collins, S.J. Schnitt HER2 protein overexpression in estrogen receptor-positive ductal carcinoma in situ of the breast: frequency and implications for tamoxifen therapy Mod Pathol 18 2005 615 620
28. L.A. Carey, C.M. Perou, C.A. Livasy, L.G. Dressler, D. Cowan, K. Conway, G. Karaca, M.A. Troester, C.K. Tse, S. Edmiston, S.L. Deming, J. Geradts, M.C. Cheang, T.O. Nielsen, P.G. Moorman, H.S. Earp, R.C. Millikan Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study JAMA 295 2006 2492 2502
29. J. Zhao, H. Liu, M. Wang, L. Gu, X. Guo, F. Gu, L. Fu Characteristics and prognosis for molecular breast cancer subtypes in Chinese women J Surg Oncol 100 2009 89 94
30. A. Balsari, P. Casalini, E. Tagliabue, M. Greco, S. Pilotti, R. Agresti, R. Giovanazzi, L. Alasio, C. Rumio, N. Cascinelli, M.I. Colnaghi, S. Menard Fluctuation of HER2 expression in breast carcinomas during the menstrual cycle Am J Pathol 155 1999 1543 1547
31. H.J. Huang, P. Neven, M. Drijkoningen, R. Paridaens, H. Wildiers, E. Van Limbergen, P. Berteloot, F. Amant, I. Vergote, M.R. Christiaens Hormone receptors do not predict the HER2/neu status in all age groups of women with an operable breast cancer Ann Oncol 16 2005 1755 1761
32. R. Schiff, S.A. Massarweh, J. Shou, L. Bharwani, G. Arpino, M. Rimawi, C.K. Osborne Advanced concepts in estrogen receptor biology and breast cancer endocrine resistance: implicated role of growth factor signaling and estrogen receptor coregulators Cancer Chemother Pharmacol 56 Suppl 1 2005 10 20
33. O. Fadare, F.A. Tavassoli Clinical and pathologic aspects of basal-like breast cancers Nat Clin Pract Oncol 5 2008 149 159
34. T. Sorlie, C.M. Perou, R. Tibshirani, T. Aas, S. Geisler, H. Johnsen, T. Hastie, M.B. Eisen, M. van de Rijn, S.S. Jeffrey, T. Thorsen, H. Quist, J.C. Matese, P.O. Brown, D. Botstein, P. Eystein Lonning, A.L. Borresen-Dale Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications Proc Natl Acad Sci U S A 98 2001 10869 10874
35. E.J. Sanders, E. Parker, C. Aramburo, S. Harvey Retinal growth hormone is an anti-apoptotic factor in embryonic retinal ganglion cell differentiation Exp Eye Res 81 2005 551 560
36. E.K. Keeton, M. Brown Coregulator expression and breast cancer: improving the predictive power of estrogen receptor α Clin Cancer Res 9 2003 1229 1230